CROP Has a 50% Net Royalty on “Air Chronic” Vaporizer Line
Momentum Public Relations
Press Release: August 07, 2018
CROP Infrastructure Corp. (CSE: CROP) (OTCMKTS: CRXPF) (“CROP” or the “Company”) is pleased to announce a 50% net royalty on the Air Chronic Vaporizer line now available for pre-order at www.AIRChronic.com.
Air Chronic Vaporizers are a high quality low cost product that can be used with cannabis, tobacco and oils and sell for $79.99 USD. CROP will fund and assist Air Chronic with a social media marketing campaign targeting influencers in the cannabis space in order to gain brand awareness for the line.
A 2017 global e-cigarette and vaporizer market analysis and trends report states that the market is poised to grow at a CAGR of around 20.8% over the next decade to reach approximately USD $61.4 billion by 2025. Some of the prominent trends that the market is witnessing include the combination of E-cigarette/Vapes and cannabis as well as improvements in device technology and product innovation.1
“Vaping” is short for “vaporization” and refers to a method of cannabis consumption in which the user inhales cannabis “vapor” or aerosol. To create this vapor the active compounds in cannabis are heated at low temperatures. Unlike with smoking cannabis, no combustion or burning takes place at these lower temperatures so there is no smoke; “the cannabis vaporizer appears to be an ideal harm-reduction approach to safer use,” researchers concluded in 2015. Another recent study concluded cannabis heated to 200°C vaporized THC without creating several carcinogens associated with combustion, including benzene, toluene and naphthalene. Some cannabis users prefer vaping over smoking because it involves less side effects and risks for the respiratory system.2
CROP Infrastructure Director & CEO Michael Yorke states: “CROP continues to diversify its portfolio of cannabis related assets with the addition of this net 50% royalty on the Air Chronic Vaporizer line. Vaping is an increasing trend amongst cannabis users due to its ease of use and number of benefits compared to traditional consumption methods. We are excited by the initial social interest in Air Chronic Vapes and are pleased to offer this quality product at an extremely competitive price compared to similar models.”
Please visit www.airchronic.com to pre-order and follow the company at instagram.com/air.chronic.
About CROP
CROP Infrastructure Corp. is publicly listed on the Canadian Securities Exchange and trades under the symbol “CROP” and in the US under the symbol “CRXPF”. CROP is primarily engaged in the business of investing, constructing, owning and leasing greenhouse projects as part of the provision of turnkey real estate solutions for lease-to-licensed cannabis producers and processors offering best-in-class operations. The Company’s portfolio of projects includes cultivation properties in California, Washington State, Nevada, Italy, Jamaica and a joint venture on West Hollywood and San Bernardino dispensary applications. CROP has developed a portfolio of 15 Cannabis brands and has US and Italian distribution rights to a line of over 55 topical cannabis products from The Yield Growth Corp.
Company Contact
Michael Yorke – CEO & Director
E-mail: info@cropcorp.com
Website: www.cropcorp.com
Phone: (604) 484-4206
- Published in Business, CROP Infrastructure, Medical Marijuana, News Home
CROP Provides Update on 25 Acre Hemp Farm in Italy
Momentum Public Relations
Press Release: August 02, 2018
CROP Infrastructure Corp. (CSE: CROP) (OTCMKTS: CRXPF) (“CROP” or the “Company”) provides the following update on the company’s joint venture; Xhemplar hemp farm in Italy. The 25-acre property was planted less than 50 days ago, has now produced approximately 600,000 healthy hemp plants. The plants are expected to be harvested in the next 20 days.
Furthermore, the joint venture has erected three drying facilities in the preparation for saleable dried hemp biomass. The company has also identified multiple locations for an extraction facility.
The joint venture’s high CBD hemp will be sold as biomass or processed into CBD isolate for international markets. The joint venture’s products will be branded under XHemplar and CROP brands Tiffany CBD and Hempire Italia.
According to Arcview Market Research and its partner, BDS Analytics, government-subsidized health care spending (worldwide market at $1.3-trillion) is expected to make Europe among the fastest growing and largest medical cannabis markets in the world. Arcview expects Italy to be the second largest cannabis market in Europe by 2027 with $1.2 billion in sales.
CROP Infrastructure Director & CEO Michael Yorke states: “The company is extremely encouraged by the fast pace of our partners at XHemplar having advanced into production in Italy. CROPs portfolio of cannabis infrastructure assets now includes cultivation properties in California, Washington State, Nevada, Italy and Jamaica. CROP also holds minority interests in West Hollywood and San Bernardino dispensary applications. Management will continue to aggressively pursue new international opportunities and expand its portfolio of tenant growers and infrastructure assets in strategic jurisdictions.”
XHemplar Chairman and CROP Infrastructure VP of M&A, EMEA Andrea Castiglione states: “We’re looking forward to CROP building out the extraction facility and unlocking the true value of the hemp plant. In 2019 we will look to increase the scale of our operations and asset base in Italy with CROP Infrastructure.”
About CROP
CROP Infrastructure Corp. is publicly listed on the Canadian Securities Exchange and trades under the symbol “CROP” and in the US under the symbol “CRXPF”. CROP is primarily engaged in the business of investing, constructing, owning and leasing greenhouse projects as part of the provision of turnkey real estate solutions for lease-to-licensed cannabis producers and processors offering best-in-class operations. The Company’s portfolio of projects includes cultivation properties in California, Washington State, Nevada, Italy, Jamaica and a joint venture on West Hollywood and San Bernardino dispensary applications. CROP has developed a portfolio of 15 Cannabis brands and has US and Italian distribution rights to a line of over 55 cannabis topical products from The Yield Growth Corp.
- Published in Business, CROP Infrastructure, Medical Marijuana, News Home